Skip to main content
AVECHO BIOTECHNOLOGY LIMITED logo

AVECHO BIOTECHNOLOGY LIMITED — Investor Relations & Filings

Ticker · AVE ISIN · AU0000047441 LEI · 529900FA9G9T82C2LV25 ASX Manufacturing
Open in API
Filings indexed 881 across all filing types
Latest filing 2014-02-27 Annual Report
Country AU Australia
Listing ASX AVE

About AVECHO BIOTECHNOLOGY LIMITED

https://avecho.com.au/

Avecho Biotechnology Limited develops and commercializes human and animal health products using its proprietary drug delivery system, Tocopheryl Phosphate Mixture (TPM®). Derived from Vitamin E, TPM® is designed to enhance the solubility and absorption of active ingredients through the skin and digestive tract. The company focuses on applying this technology to pharmaceuticals, nutraceuticals, and animal health sectors. A primary area of development includes medicinal cannabis, where Avecho has produced high-bioavailability cannabidiol (CBD) softgel capsules for therapeutic use. The company’s portfolio also includes applications in pain management and dermatology, leveraging TPM® to improve the delivery of poorly soluble molecules and enhance the efficacy of existing treatments.

Recent filings

Filing Released Lang Actions
December 2013 Appendix 4E - Annual Financial Report 79 pages 438.1KB
Annual Report Classification · 95% confidence The document is titled 'Appendix 4E Preliminary final report Period ending on or after 31 December 2013' and references ASX listing rule 4.3. It contains detailed financial results for the year ended 31 December 2013, including revenues, net loss, cash position, research and development activities, commercial developments, and forward-looking statements. It also references attached financial statements such as the Consolidated Statement of Comprehensive Income, Statement of Financial Position, and Statement of Cash Flows. The document is comprehensive, covering a full fiscal year, and includes substantive financial data and analysis. Appendix 4E is a known Australian Securities Exchange (ASX) form used for preliminary final reports, which are equivalent to annual reports or 10-K filings in other jurisdictions. Given the detailed financial performance and the period covered (full year), this document fits the definition of an Annual Report (10-K). It is not merely an announcement or a certification, but a full report with financial statements and notes. Therefore, the correct classification is Annual Report (10-K). FY 2013
2014-02-27 English
Novartis Launches Voveran TPM Gel in India 2 pages 60.3KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Phosphagenics Limited regarding the launch of a pharmaceutical product (Voveran TPM gel) in India. It provides details about the product, the partnership with Novartis and Themis, and some background on the company and investment risks. There are no financial statements, regulatory certifications, voting results, or management changes. The document is an announcement of a commercial development rather than a financial report or regulatory filing. It is not a report publication announcement since it does not mention any report being attached or published. The content fits best under a general regulatory announcement category as it does not fit into any other specific financial or corporate filing categories.
2014-01-20 English
Reconciliation of Non-Quoted Securities - Conditional Rights 13 pages 285.3KB
Capital/Financing Update Classification · 100% confidence The document is a detailed announcement regarding the issuance and lapse of non-quoted securities, specifically Conditional Rights and Options, by Phosphagenics Limited. It includes an Appendix 3B form, which is a standard ASX (Australian Securities Exchange) form used for new issue announcements, applications for quotation of additional securities, and related agreements. The document contains detailed information about the securities issued, the number of securities, terms, and compliance with ASX rules. It is not a financial report, earnings release, or management discussion but rather a regulatory announcement about capital changes and securities issuance. Therefore, the document fits the category of a Capital/Financing Update (CAP).
2013-12-19 English
Phosphagenics - TPM in Dairy Feed Inclusion Technology 2 pages 150.3KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Phosphagenics Limited, dated 12 December 2013, describing the commercial promise of a new feed inclusion technology (Udder-Mate®) that reduces antibiotic use in dairy cows. It includes details about the product, its licensing, and ongoing research collaborations. The document is a press release-style announcement focusing on product development and commercial progress rather than financial results, regulatory filings, or shareholder meeting materials. It does not contain financial statements, voting results, management changes, or legal proceedings. It is not a report or transcript but a corporate announcement about a product and its commercial potential. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous corporate announcements that do not fit other specific categories.
2013-12-11 English
POH Signs Further Deed of Settlement with Final Parties 2 pages 131.6KB
Legal Proceedings Report Classification · 95% confidence The document is a company announcement from Phosphagenics Limited regarding a Deed of Settlement with parties involved in invoice irregularities and misappropriation of funds. It discusses legal settlements and ongoing litigation but does not contain financial statements, detailed financial performance, or regulatory certifications. The content is focused on legal and settlement updates rather than financial results or management changes. It is not a full audit report, annual or interim report, or earnings release. The document is a regulatory announcement about legal and settlement matters, fitting best under Legal Proceedings Report (LTR).
2013-11-07 English
Phosphagenics Issues Proceedings Against Former Employee 1
Legal Proceedings Report Classification · 100% confidence The document is a market announcement from Phosphagenics Limited regarding legal proceedings initiated against a former employee for misappropriation of funds. It is a legal update about a lawsuit filed in the Supreme Court of Victoria. There is no financial data, no report attached or referenced, and no mention of annual or quarterly results, governance changes, or capital activities. The content fits the description of a Legal Proceedings Report, which covers updates on significant lawsuits or regulatory actions involving the company.
2013-10-30 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.